********************************************** * EGF-like domain cysteine pattern signature * ********************************************** A sequence of about thirty to forty amino-acid residues long found in the sequence of epidermal growth factor (EGF) has been shown [1,2,3,4,5] to be present, in a more or less conserved form, in a large number of other proteins. The proteins currently known to contain one or more copies of an EGF-like pattern are listed below (references are only provided for very recently sequenced proteins). - Transforming growth factor alpha (TGF-alpha). - Amphiregulin, a growth factor. - Schwannoma-derived growth factor (SDGF). - Betacellulin, a growth factor [6]. - Growth factor related proteins from Vaccinia, Myxoma, and Shope fibroma viruses. - Coagulation factors VII, IX, X (once) and XII (twice). - Coagulation associated proteins C, S and Z (once). - Urokinase and tissue plasminogen activator (TPA) (once). - Complement components C6, C7, C8 alpha and beta chains, and C9 (once). - Fibronectin (twice). - Laminin subunits A (15 times), B1 (13 times) and B2 (12 times). - Tenascin, an extracellular matrix protein (14 times). - Nidogen (also called entactin), a basement membrane protein (once). - Agrin, a basal lamina protein that causes the aggregation of acetylcholine receptors on cultured muscle fibers (4 times). - Aggrecan (once) and versican (twice), two large proteoglycans. - Selectins, cell adhesion proteins such as ELAM-1 (E-selectin), GMP-140 (P-selectin), or the lymph-node homing receptor (L-selectin) (once). - Transforming growth factor beta-1 binding protein (TGF-B1-BP) (16 times). - Drosophila neurogenic proteins: Notch (36 times), Delta (9 times), and Slit (7 times). - Drosophila epithelial development protein Crumbs (30 times). - Drosophila ectodermal development protein Serrate (14 times). - Caenorhabditis elegans developmental proteins lin-12 (13 times) and glp-1 (10 times). - Sea urchin protein uEGF-1 (at least 9 times). - Human teratocarcinoma-derived growth factor 1 (TDGF-1) (CRIPTO protein) (once). - Milk fat globule-EGF factor 8 (MFG-E8) (twice). - Tyrosine-protein kinase receptors tek and tie (3 times) [7]. The functional significance of EGF domains in what appear to be unrelated proteins is not yet clear. However, a common feature is that these repeats are found in the extracellular domain of membrane-bound proteins or in proteins known to be secreted. The EGF domain includes six cysteine residues which have been shown (in EGF) to be involved in disulfide bonds. The schematic representation of the EGF-like type A domain is shown here: +-----------+ +--------+ | | | | xxxCxxxxCxxxxxCxxxxxCxCxxxxxxxxCxxx | | ************ +----------+ 'C': conserved cysteine involved in a disulfide bond. '*': position of the pattern. We have used the region which includes the last three cysteines of the domain as a consensus pattern. -Consensus pattern: C-x-C-x(5)-G-x(2)-C [The three C's are involved in disulfide bonds] -Sequences known to belong to this class detected by the pattern: ALL. -Other sequence(s) detected in SWISS-PROT: 38 other proteins. It is also found twice in the beta chain of the integrin family of proteins. The presence of cysteine-rich repeat patterns in these proteins had already been noted but they were said to be dissimilar with the EGF pattern [8]. -Note: the residue in position -2 to the glycine is very often an aromatic (F, Y or W) residue. -Note: this pattern does not detect some of the repeats of laminins A, B1 and B2, Crumbs, Notch, TGF-B1-BP, and lin-12. -Last update: June 1994 / Text revised. [ 1] Davis C.G. New Biol. 2:410-419(1990). [ 2] Blomquist M.C., Hunt L.T., Barker W.C. Proc. Natl. Acad. Sci. U.S.A. 81:7363-7367(1984). [ 3] Barker W.C., Johnson G.C., Hunt L.T., George D.G. Protein Nucl. Acid Enz. 29:54-68(1986). [ 4] Doolittle R.F., Feng D.F., Johnson M.S. Nature 307:558-560(1984). [ 5] Appella E., Weber I.T., Blasi F. FEBS Lett. 231:1-4(1988). [ 6] Shing Y.W., Christofori G., Hanahan D., Ono Y., Sasada R., Igarashi K., Folkman J. Science 259:1604-1607(1993). [ 7] Ziegler S.F., Bird T.A., Schneringer J.A., Schooley K.A., Baum P.R. Oncogene 8:663-670(1993). [ 8] Tamkun J.W., DeSimone D.W., Fonda D., Patel R.S., Buck C., Horwitz A.F., Hynes R.O. Cell 46:271-282(1986).